U.S. Senator Tammy Baldwin Calls on Pharmaceutical Companies to Explain Skyrocketing Insulin Prices
Senators: “It is clear that these steep price increases are resulting in patients lacking access to the life-saving medications they need.”
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin (D-WI), a member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, joined her colleagues to call on executives at Eli Lilly, Novo Nordisk, and Sanofi— the three insulin manufacturers in the U.S.—demanding information about rising insulin costs and questioning the companies that recently decided to raise prices for the life-saving drug even further.
“According to the World Health Organization, insulin is an essential medicine, meaning that access to this drug at a price that individuals and communities can afford is a basic requirement of a functioning health care system. Unfortunately, rapidly increasing insulin prices mean that for many patients, access to this essential medicine is threatened. Patients have had to resort to desperate measures when confronted with increased insulin prices or high cost-sharing for their prescriptions. Some patients have turned to GoFundMe pages to request help paying for insulin, and one in four diabetic patients report rationing the medication because of the cost, with potentially devastating consequences. It is clear these steep price increases are resulting in patients lacking access to the life-saving medications they need,” wrote the Senators.
The letter was also signed by Senators Bob Casey (D-PA), Maggie Hassan (D-NH), Doug Jones (D-AL), Tim Kaine (D-VA), Chris Murphy (D-CT), Patty Murray (D-WA), Jacky Rosen (D-NV), Bernie Sanders (I-VT), Tina Smith (D-MN) and Elizabeth Warren (D-MA).
The letters are available below.
- A PDF of the letter to Eli Lilly is available here.
- A PDF of the letter to Novo Nordisk is available here.
- A PDF of the letter to Sanofi is available here.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
U.S. Senator Tammy Baldwin Introduces Bipartisan Legislation to Help Wisconsin Craft Breweries Create Jobs and Grow Their Business
Feb 20th, 2019 by U.S. Sen. Tammy BaldwinCraft Beverage Modernization and Tax Reform Act would permanently cut taxes and modernize outdated regulations for craft breweries
U.S. Senator Tammy Baldwin Helps Reintroduce Legislation to Create State Public Health Care Option
Feb 15th, 2019 by U.S. Sen. Tammy BaldwinState Public Option Act will allow states to create a Medicaid buy-in program for all their residents, regardless of income
U.S. Senator Tammy Baldwin Introduces Legislation to Protect Americans with Pre-existing Conditions
Feb 14th, 2019 by U.S. Sen. Tammy BaldwinBill would stop Trump Administration scheme to promote “junk” health plans that lack protections for individuals with pre-existing conditions and would increase costs for millions of Americans
